R. Silva Et Al. , "Long-term Safety of Ranibizumab in Neovascular Age-related Macular Degeneration Reply," OPHTHALMOLOGY , vol.120, no.9, 2013
Silva, R. Et Al. 2013. Long-term Safety of Ranibizumab in Neovascular Age-related Macular Degeneration Reply. OPHTHALMOLOGY , vol.120, no.9 .
Silva, R., Axer-Siegel, R., Eldem, B., Guymer, R., Kirchhof, B., Papp, A., ... Seres, A.(2013). Long-term Safety of Ranibizumab in Neovascular Age-related Macular Degeneration Reply. OPHTHALMOLOGY , vol.120, no.9.
Silva, Rufino Et Al. "Long-term Safety of Ranibizumab in Neovascular Age-related Macular Degeneration Reply," OPHTHALMOLOGY , vol.120, no.9, 2013
Silva, Rufino Et Al. "Long-term Safety of Ranibizumab in Neovascular Age-related Macular Degeneration Reply." OPHTHALMOLOGY , vol.120, no.9, 2013
Silva, R. Et Al. (2013) . "Long-term Safety of Ranibizumab in Neovascular Age-related Macular Degeneration Reply." OPHTHALMOLOGY , vol.120, no.9.
@article{article, author={Rufino Silva Et Al. }, title={Long-term Safety of Ranibizumab in Neovascular Age-related Macular Degeneration Reply}, journal={OPHTHALMOLOGY}, year=2013}